Safe application – our foremost priority
Process safety and health integrity for you as our valued customer and/or user of our plasma sources is guaranteed by our compliance of the five security features:
No current flow through skin
We use so-called “indirect plasma sources” in which the patient does not act as a counter electrode and consequently there is no current flow through the patient.
Within the world’s first and largest clinical trial with cold plasma (over a period of eight years) terraplasma’s technology was tested and found to be safe for application. New plasma sources are scaled and tested according to the gained clinical data.
The concentration of produced trace gases such as O3, NO or NO2 must be below the statutory legal limits.
Low UV radiation
The design of plasma sources must aim to only produce a minimum of UV radiation (especially UV-C and UV-B). Limits for intact human skin must not be exceeded.
Cell and tissue research
Before cold plasma equipment is authorized for application, research on eukaryotic cells and tissue must be carried out in vitro and ex vivo. These tests include vitality, toxicity and mutagenicity analyses as well as investigations to ensure exclusion of the induction of histological changes and DNA damage.